The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.
复制标题
DOI:
10.1038/nrd4161
复制
发表时间:
2014-01
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
The Hippo signaling pathway is an emerging growth control and tumor suppressor pathway that regulates cell proliferation and stem cell functions. Defects in Hippo signaling and hyperactivation of its downstream effectors YAP and TAZ contribute to the development of cancer, suggesting that pharmacological inhibition of YAP and TAZ activity may be an effective anticancer strategy. Conversely, YAP and TAZ can also play beneficial roles in stimulating tissue repair and regeneration following injury, therefore activation of YAP and TAZ may be useful in these contexts. Recently, a complex network of intracellular and extracellular signaling pathways that modulate YAP and TAZ activities have been identified. Here we review the regulation of the Hippo signaling pathway, its functions in normal homeostasis and disease, and recent progress in the identification of small molecule pathway modulators.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
DOI:
10.1073/pnas.1113882109
发表时间:
2012-01-10
影响因子:
11.1
作者:
Chen, Chiao-Lin;Schroeder, Molly C.;Halder, Georg
通讯作者:
Halder, Georg
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
4.8
作者:
Chen, HI;Einbond, A;Sudol, M
通讯作者:
Sudol, M
影响因子:
9.2
作者:
Bennett, F. Christian;Harvey, Kieran F.
通讯作者:
Harvey, Kieran F.